Bacterial quorum sensing protein (QS protein)

Bacterial quorum sensing proteins are a specialized class of enzymes and transcription factors that facilitate intercellular communication among bacteria to coordinate group behaviors based on population density (Miller & Bassler, 2001). This system typically involves the production of signaling molecules called autoinducers by synthase proteins, such as LuxI-type enzymes, and their subsequent detection by cognate receptor proteins, such as LuxR-type transcription factors. Once a threshold concentration of autoinducers is reached, these proteins regulate the expression of genes essential for pathogenesis, including biofilm formation, toxin production, and motility (Defoirdt, 2018). As therapeutic targets, quorum sensing proteins are the focus of anti-virulence strategies aimed at disarming pathogens without imposing the strong selective pressure for survival associated with traditional bactericidal antibiotics (Hentzer et al., 2003). Drugs targeting these proteins, including quorum quenchers and receptor antagonists, are being explored to treat chronic and multi-drug resistant infections (Nadal Jimenez et al., 2012). For example, the macrolide antibiotic Azithromycin is known to inhibit quorum sensing in Pseudomonas aeruginosa, contributing to its efficacy in treating cystic fibrosis patients. Other experimental compounds like synthetic furanones or natural products like baicalein act by competitively binding to receptors or degrading signal molecules. These targets are particularly relevant for managing infections where biofilms protect bacteria from both the immune system and conventional antibiotics. By disrupting the communication network, these drugs can potentially restore the efficacy of the host immune response and existing antimicrobial therapies.

Other names

Quorum sensing systemAutoinducer receptorsLuxR-type proteinsLuxI-type proteinsQuorum sensing signaling proteinsLasRLasIRhlRRhlIPqsRAgrA

Inhibition of autoinducer synthesis, enzymatic degradation of autoinducer molecules (quorum quenching), or competitive antagonism of autoinducer receptors to prevent the activation of virulence-related gene expression.